Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.36 USD | -4.47% | +10.47% | +37.00% |
Mar. 07 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
Mar. 06 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
Financials (USD)
Sales 2022 | 169M | Sales 2023 | 219M | Capitalization | 45.99M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | - | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 34.36M | Net Debt 2023 | 33.62M | EV / Sales 2023 | 0.36 x |
P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.79% |
1 day | -3.01% | ||
1 week | +10.47% | ||
Current month | +11.55% | ||
1 month | +11.24% | ||
3 months | +41.22% | ||
6 months | +115.71% | ||
Current year | +37.00% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 15-10-31 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 19-04-28 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Rhind
CHM | Chairman | 61 | 08-03-31 |
Donald Shaw
BRD | Director/Board Member | 73 | 13-05-31 |
Keith Gehl
BRD | Director/Board Member | 65 | 15-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 39.82 | -0.81% | 1 932 |
24-05-16 | 40.15 | -3.14% | 11,967 |
24-05-15 | 41.45 | -1.31% | 13,444 |
24-05-14 | 42 | +10.82% | 40,364 |
24-05-13 | 37.9 | +5.13% | 28,125 |
Delayed Quote Nasdaq, May 17, 2024 at 09:50 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+37.00% | 115M | |
+5.65% | 2.99B | |
+3.05% | 2.92B | |
+10.73% | 2.19B | |
+0.92% | 1.56B | |
+3.90% | 1.4B | |
-14.88% | 494M | |
+3.49% | 445M | |
-15.78% | 368M | |
+7.19% | 188M |
- Stock Market
- Equities
- KEQU Stock